33 Although decreases in gastric emptying via GLP-1RAs help prevent overnutrition by decreasing nutrient absorption, there is concern that patients could be at risk of nutrient deficiencies driven by malabsorption from delayed gastric emptying
Now, two new late-phase clinical trials, sponsored by Eli Lilly and Company, suggest that transitioning from high dose injectable weight loss medications to either a daily pill or a lower maintenance dose can help people living with obesity to keep off most of the weight they have already lost The results of the ATTAIN-MAINTAIN and SURMOUNT-MAINTAIN trials were presented at the European Congress on Obesity and published in Previous research suggests that 1 year after stopping weight loss medication, people may regain, on average, 60% of their lost weight
The expected market launch in the second half of the year is in line with Sandozs expectations
Given the uncertainty of this outcome, additional clinical studies of obese AUD patients should explore the effects of the GLP-1R agonists on alcohol intake and body weight
Novo Nordisk A/Ss weight-loss medications are under investigation by the European Unions drug regulator after reports of suicidal risks were referred to it
It's worth noting that most helicopter speed controls and some airplane speed controls do not have a Low Voltage Cutoff, as disabling the motor in mid-air wouldn't be a good idea
